Mannkind (MNKD) Enterprise Value (2010 - 2026)
Mannkind (MNKD) reported Enterprise Value of -$134.6 million for Q1 2026, up 26.15% year-over-year from -$106.7 million in Q1 2025, and up 21.44% quarter-over-quarter from -$171.3 million in Q4 2025.
Mannkind (MNKD) Enterprise Value (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Enterprise Value data on file, last reported at -$134.6 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$134.6 million, up 26.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$134.6 million (up 26.15% YoY), and the FY2025 annual result was -$171.3 million, up 13.46% from the prior year.
- Enterprise Value improved to -$134.6 million in Q1 2026 per MNKD's latest filing, from -$171.3 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$134.6 million in Q1 2026 and troughed at -$300.7 million in Q1 2024.
- A 5-year average of -$195.6 million and a median of -$171.3 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value jumped 41.34% in 2022, then sank 81.01% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$170.8 million in 2022, then tumbled by 72.73% to -$295.1 million in 2023, then jumped by 32.91% to -$198.0 million in 2024, then increased by 13.46% to -$171.3 million in 2025, then increased by 21.44% to -$134.6 million in 2026.
- Business Quant data shows MNKD's Enterprise Value at -$134.6 million in Q1 2026, -$171.3 million in Q4 2025, and -$260.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | -134.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -134.61 Mn |
| Dec 31, 2025 | -171.35 Mn |
| Sep 30, 2025 | -260.04 Mn |
| Jun 30, 2025 | -178.99 Mn |
| Mar 31, 2025 | -182.28 Mn |
| Dec 31, 2024 | -197.99 Mn |
| Sep 30, 2024 | -252.32 Mn |
| Jun 30, 2024 | -248.49 Mn |
| Mar 31, 2024 | -300.73 Mn |
| Dec 31, 2023 | -295.10 Mn |
| Sep 30, 2023 | -141.02 Mn |
| Jun 30, 2023 | -144.35 Mn |
| Mar 31, 2023 | -166.14 Mn |
| Dec 31, 2022 | -170.85 Mn |
| Sep 30, 2022 | -165.05 Mn |
| Jun 30, 2022 | -154.15 Mn |
| Mar 31, 2022 | -162.40 Mn |
| Dec 31, 2021 | -204.12 Mn |
| Sep 30, 2021 | -139.01 Mn |
| Jun 30, 2021 | -162.47 Mn |